Dermatitis : contact, atopic, occupational, drug最新文献_第6页

Contact Sensitization to Allergens in Synthetic Hair and Related Hair Practices: A Review. 合成头发对过敏原的接触致敏及相关的美发实践：综述。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-02-12 DOI: 10.1089/derm.2024.0424

Dina Collins, JiaDe Yu

{"title":"Contact Sensitization to Allergens in Synthetic Hair and Related Hair Practices: A Review.","authors":"Dina Collins, JiaDe Yu","doi":"10.1089/derm.2024.0424","DOIUrl":"10.1089/derm.2024.0424","url":null,"abstract":" Scalp contact dermatitis (SCD) represents a less common manifestation of contact dermatitis and is susceptible to misdiagnosis due to its atypical clinical presentations, including hair thinning, eczematous lesions, and scalp pruritus. Notably, personal care products are recognized as common etiologies in the development of SCD. Synthetic hair extensions, with prevalent use in individuals of color, are also known to cause contact dermatitis, due to allergenic components such as acrylates and disperse dyes. This review summarizes documented cases of contact dermatitis secondary to synthetic hair and provides an overview of prevalent ethnic hairstyling practices associated with synthetic hair installation. Hair styling practices detailed include braids and installation of wigs, and the related hair products that may be used to maintain these hairstyling practices. Upon surveying common hair styling products utilized, the most common hapten observed was fragrance. Ultimately, contact dermatitis stemming from synthetic hair warrants consideration as a pivotal differential diagnosis in individuals who regularly utilize synthetic hair products.","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":"456-463"},"PeriodicalIF":3.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Tofacitinib as a Possible Treatment for Tacrolimus-Induced Stevens-Johnson Syndrome: A Case Report. 托法替尼可治疗他克莫司诱发的史蒂文斯-约翰逊综合征：病例报告。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2024-11-27 DOI: 10.1089/derm.2024.0229

Man Li, Hsin-Yi Huang, Jun Lin, Xianlin Zeng, Guixiang Zhang, Yongxin Xie, James Cheng-Chung Wei

引用次数: 0

This Report Details a Case of Allergic Contact Dermatitis Resulting From Exposure to Chromium in the Clasp of an Apple Watch Band. 本报告详细介绍了一例因接触苹果手表表带搭扣中的铬而引起的过敏性接触性皮炎。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2024-12-23 DOI: 10.1089/derm.2024.0171

Maki Hosoki, Toyoko Tajima, Mayu Miyagi, Yoshizo Matsuka

引用次数: 0

Meta-Analysis on Patch Testing in Black Individuals. 黑人个体斑贴测试的meta分析。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-02-11 DOI: 10.1089/derm.2024.0439

Dina Collins, Peter Gaccione, Lisa Liang Philpotts, JiaDe Yu

引用次数: 0

Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study. Dupilumab治疗有或无特应性合并症的老年患者的内源性和外源性特应性皮炎的有效性和安全性：一项回顾性研究

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-02-12 DOI: 10.1089/derm.2024.0402

Kexin Zhao, Ge Yang, Xiyuan Zhou, Jianing Yang, Juhua Zhao, Jing Xiang, Xuejun Chen, LiXia Zhang

{"title":"Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study.","authors":"Kexin Zhao, Ge Yang, Xiyuan Zhou, Jianing Yang, Juhua Zhao, Jing Xiang, Xuejun Chen, LiXia Zhang","doi":"10.1089/derm.2024.0402","DOIUrl":"10.1089/derm.2024.0402","url":null,"abstract":" Background: Despite the widespread use of dupilumab in atopic dermatitis (AD) treatment, evidence supporting its use in older patients with intrinsic AD (IAD) versus those with extrinsic AD (EAD) and in those with and without atopic comorbidities remains limited. Objective: We aimed to assess the clinical efficacy and safety of dupilumab treatment in elderly patients with IAD versus EAD and in those with and without atopic comorbidities. Methods: We enrolled 113 older patients with severe AD who received dupilumab for 48 weeks. The inclusion criteria were age ≥60 years and Scoring Atopic Dermatitis ≥25. Patients were classified as IAD or EAD and based on the presence of atopic comorbidities. The primary outcome was a reduction in the Eczema Area and Severity Index, Numeric Rating Scale, Dermatology Life Quality Index, and Atopic Dermatitis Control Test. Secondary measures were the types and rates of adverse events. Results: Dupilumab treatment resulted in a substantial improvement in AD symptoms, with no significant difference between patients with IAD and EAD or those with and without atopic comorbidities. Conclusions: Dupilumab showed good efficacy and safety in improving AD symptoms in older patients, irrespective of IAD or EAD subtypes and the presence of atopic comorbidities.","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":"509-515"},"PeriodicalIF":3.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143401002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Colophony in Dentistry: Routes of Exposure and Reported Reactions. 树脂在牙科：接触途径和报告的反应。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-01-16 DOI: 10.1089/derm.2024.0356

Brailyn Weber, Sarah Karels, Anne Neeley

{"title":"Colophony in Dentistry: Routes of Exposure and Reported Reactions.","authors":"Brailyn Weber, Sarah Karels, Anne Neeley","doi":"10.1089/derm.2024.0356","DOIUrl":"10.1089/derm.2024.0356","url":null,"abstract":" Colophony is a solid form of resin derived from coniferous trees that has both adhesive and water-resistant properties. For these reasons, this allergen is incorporated into many personal care products, medications, and occupational materials, and is thus commonly implicated in allergic contact dermatitis. Dedicated \"dental\" allergen series often include colophony, but dermatologists are likely not well-versed on its use in a dental setting. There are several routes of exposure to colophony via dental materials, including periodontal dressings, cements, and varnishes. Contact with these products by an individual with a colophony allergy has the potential to produce oral reactions, but cases in the literature are sparse, with almost no publications on this topic in the past decade. This article reviews the existing cases of oral reactions to colophony and discusses their relevance in medical practice. The most common oral reaction identified was allergic contact stomatitis arising after dental interventions in which colophony-containing dressings or fluoride varnishes were used. Cases of allergic contact cheilitis, oral lichen planus, and systemic contact dermatitis have also been described. Both dentists and dermatologists should be aware of colophony's ability to produce allergic contact reactions, especially in the form of stomatitis or cheilitis. For known colophony-allergic patients, dermatologists should provide counseling regarding potential exposure in dental materials and procedures.","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":"452-455"},"PeriodicalIF":3.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

"Effects of Allergen Avoidance in Patients with Frontal Fibrosing Alopecia: A Retrospective Cohort Analysis". 过敏原避免对额部纤维化性脱发患者的影响：回顾性队列分析。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-03-31 DOI: 10.1089/derm.2024.0347

Jeremiah S Truel, Daniel I Schlessinger, Michael Lazarus, Carolena Rojas Marcos, David M Sheinbein, Caroline M Mann

引用次数: 0

Natural but Not Harmless: A Case of Pustular Allergic Contact Dermatitis Triggered by Propolis-Enriched Honey. 信：自然但并非无害：一个由富含蜂胶的蜂蜜引发的脓疱性过敏性接触性皮炎病例。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2025-07-14 DOI: 10.1177/17103568251359602

Mohamed Amine Foued, Nesrine Ben Salah, Daly Gammara, Manel Ben Belgacem, Asma Ben Mabrouk, Hichem Belhadjali, Jameleddine Zili

引用次数: 0

Increasing Use of Dupilumab and Decreasing Use of Patch Testing in Medicare Patients from 2017 to 2022: A Claims Database Study. 从 2017 年到 2022 年，医疗保险患者中杜匹单抗的使用量不断增加，贴片测试的使用量不断减少：一项报销数据库研究。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2024-11-13 DOI: 10.1089/derm.2024.0416

Kathyana P Santiago Mangual, Akash Rau, Jane M Grant-Kels, Arianne Shadi Kourosh, Jenny E Murase

引用次数: 0

A Case of Twenty-Nail Dystrophy Treated with Dupilumab. Dupilumab治疗二十甲营养不良1例。

IF 3.2

Dermatitis : contact, atopic, occupational, drug Pub Date : 2025-09-01 Epub Date: 2024-12-24 DOI: 10.1089/derm.2024.0341

Jinru Lin, Yan Yu, Huiping Wang

引用次数: 0